[1]武欣,姜桦.悠久传承，砥砺前行——新时代的红房子妇瘤科需要无限开拓的视野[J].复旦学报(医学版),2024,51(05):630-633.
[2]Arbyn M., Weiderpass E., Bruni L., de Sanjose S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 2020;8:e191–e203. doi: 10.1016/S2214-109X(19)30482-6.
[3]崔玲,王芳,林永红.妇科恶性肿瘤手术中的生育力保护策略[J].中国计划生育和妇产科,2024,16(04):11-16.
[4]刘妍,黄莉.妇科恶性肿瘤患者的生育力保护[J].青岛医药卫生,2024,56(02):145-148.
[5]Qian Q,Yang J,Cao D, et al. Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China. J Gynecol Oncol 2014;25:293–300.
[6]Margolis B, Cagle-Colon K, Chen L, Tergas AI, Boyd L, Wright JD. Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer. Int J Gynecol Cancer. 2020 Jun;30(6):735-743. doi: 10.1136/ijgc-2019-000849. Epub 2020 Mar 15. PMID: 32179697.
[7]Nezhat C, Roman RA, Rambhatla A, Nezhat F. Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: A systematic review. Fertil Steril. 2020;113:685–703. doi: 10.1016/j.fertnstert.2020.02.003.
[8]Guo J, Zhang Y, Chen X, Sun L, Chen K, Sheng X. Surgical and Oncologic Outcomes of Radical Abdominal Trachelectomy Versus Hysterectomy for Stage IA2-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2019 Mar-Apr;26(3):484-491. doi: 10.1016/j.jmig.2018.06.006. Epub 2018 Jun 13. PMID: 29908338.
[9]Morice P, Maulard A, Scherier S, Sanson C, Zarokian J, Zaccarini F, et al. Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review. Gynecol Oncol. 2022;165:169–83. doi: 10.1016/j.ygyno.2022.01.023
[10]Huang W, Wang Y, Yang F, Luo N, Ai G, Wu Y, et al. The impaction of laparoscopic versus laparotomy for lymphovascular space invasion of early cervical cancer: A multicenter retrospective study. Gynecol Minim Invasive Ther. 2022;11:17–22. doi: 10.4103/GMIT.GMIT_121_20.
[11] Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: A systematic review. Lancet Oncol. 2016;17:e240–53. doi: 10.1016/S1470-2045(16)30032-8.
[12]Salman L, Covens A. Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications. Curr Oncol. 2024 Jan 4;31(1):296-306. doi: 10.3390/curroncol31010019. PMID: 38248104; PMCID: PMC10814061.
[13] Liu CK, Huang KG, Chen MJ, Lu CH, Hwang SF, Sun L, Hsu ST. The Current Trend of Fertility Preservation in Patients with Cervical Cancer. Gynecol Minim Invasive Ther. 2023 Dec 7;13(1):4-9. doi: 10.4103/gmit.gmit_34_23. PMID: 38487609; PMCID: PMC10936714.
[14]Wang Y，Yang JX.Fertility-preserving treatment in women with early endometrial cancer：the Chinese experience［J］. Cancer Manag Res，2018，10：6803-6813.
[15]潘凌亚,陈佳钰.早期子宫内膜癌生育力保护的治疗和长期管理[J].中国实用妇科与产科杂志,2022,38(11):1068-1074.DOI:10.19538/j.fk2022110103.
[16]程傲霜，李晶，林中秋《. 2020 ESGO-ESTRO-ESP子宫内膜癌患者管理指南》解读［J］.中国实用妇科与产科杂志，2021，37（3）：336-341.
[17]Mitsuhashi A，Shozu M.New therapeutic approaches for the fertility-sparing treatment of endometrial cancer［J］.J Obstet Gyn⁃aecol Res，2020，46（2）：215-222.
[18]Chen J，Cao D，Yang J，et al.Fertility-sparing treatment for endometrial cancer or atypical endometrial hyperplasia patients
with obesity［J］.Front Oncol，2022，12：812346.
[19]Mazzon I，Corrado G，Morricone D，et al.Reproductive preservation for treatment of stage ⅠA endometrial cancer in a young
woman：hysteroscopic resection［J］.Int J Gynecol Cancer，2005，15（5）：974-978.
[20]程文俊.卵巢恶性肿瘤生育力保存问题[J].中国实用妇科与产科杂志,2024,40(11):1082-1086.DOI:10.19538/j.fk2024110107.
[21]颜磊,陈子江.卵巢恶性肿瘤治疗后的生育和助孕策略[J].实用妇产科杂志,2016,32(11):809-811.
[22]Crafton SM,Cohn DE,Llamocca EN,et al.Fertility-sparing sur‐gery and survival among reproductive-age women with epitheli‐al ovarian cancer in 2 cancer registries[J].Cancer,2020,126(6):1217-1224.
[23]Pérez-Quintanilla M,Del Real-Ordoñez S,Gallardo-Alvarado L,et al.Fertility-sparing treatment for epithelial ovarian can‐cer:a literature review[J].Chin Clin Oncol,2020,9(4):48.
[24]Berek JS,Renz M,Keho ES,et al.Cancer of the ovary,fallopi‐an tube,and peritoneum:2021 update[J].Int J Gynaecol Ob‐stet,2021,155(Suppl 1):61-85.
[25]Pacheco F,Oktay K.Current success and efficiency of autolo‐gous ovarian transplantation:a meta-analysis[J].Reprod Sci,2017,24(8):1111-1120.
[26]Azim HA Jr,Kroman N,Paesmans M,et al.Prognostic impact of pregnancy after breast cancer according to estrogen receptor status:a multicenter retrospective study[J].J Clin Oncol,2013,31(1):73-79.
